ABILIFY MAINTENA (aripiprazole) FULL PRESCRIBING INFORMATION. 12. Otsuka Pharmaceutical Press Release [J].
Diagnosis of bipolar disorder;. 2. Request is for Abilify Maintena;. 3 Accessed . Coding Implications. Codes referenced in this
The NDC code is assigned by the FDA to the product Abilify Maintena which is a human prescription drug product labeled by Otsuka America Pharmaceutical, Inc. The generic name of Abilify Maintena is aripiprazole. The product's dosage form is kit.
Maintena, Aristada, Aristada Initio, Abilify MyCite). □ Asenapine NDC/HCPCS (J Code). Strength. Dosage Form. Quantity. Directions for Use. Kansas
HCPCS Code J0401 for Injection, aripiprazole (abilify maintena), 1 mg.
Abilify Maintena PBS Information: Authority required (STREAMLINED). Code: 4246 for schizophrenia. This product is not listed on the PBS for
ABILIFY MAINTENA is a Psychiatric drug manufactured by Otsuka America and administered via the Intramuscular route of administration. The J Code: J0401 is aligned to the drug ABILIFY MAINTENA.
Always search by J-Code AND by. Drug Name because J-Codes change. Note: See Abilify Maintena. Yes. J2024. Aripiprazole, injection extended release.
code via email. Psychopharmacology and Clinical Application of Aripiprazole Long Acting Injections – Review of Abilify Maintena Aristada.
R.